BXRX Baudax Bio, Inc.

Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

$0.83
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/22/2019
Outstanding shares:  6,422,762
Average volume:  160,987
Market cap:   $5,427,234
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -0.40
PB ratio:   0.55
PS ratio:   6.60
Return on equity:   -160.79%
Net income %:   -1,905.84%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy